New publication from National University of Singapore using Attana Technology to study Immune Response from Tuberculosis Exposed Healthy Individuals

In a new paper in npj Vaccines, 8, Article number: 127 (2023) , the team at NUS, in collaboration with several research groups in USA, UK and, China has studied the immune response from healthy individuals that have been exposed to Tuberculosis (TB). TB is an airborne disease caused by Mycobacterium tuberculosis. Identifying the critical components in the antibody repertoires from immune, chronically exposed and, healthy individuals can be used for understanding how natural protection occurs. These findings have implications for future